Trials / Completed
CompletedNCT05176535
Determination of Vaginal Colonization and the Effect of an Oral Probiotic (PROSALVAG)
Study to Determine Vaginal Colonization and Effect of an Oral Probiotic That Contains L.Rhamnosus, L. Plantarum and L. Crispatus in Women (PROSALVAG)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Fertypharm · Industry
- Sex
- Female
- Age
- 35 Years – 43 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to determine the efficacy of an oral nutraceutical with probiotics in restore vaginal health.
Detailed description
After being informed about the study, all patients meeting the inclusion/exclusion criteria and giving written informed consent will receive a nutraceutical containing L. rhamnosus, L. plantarum and L. crispatus once daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | FertyBiotic Balance | Lactobacillus rhamnosus BPL 205, Lactobacillus plantarum BPL207 and Lactobacillus crispatus BPL209 |
Timeline
- Start date
- 2021-10-11
- Primary completion
- 2024-01-15
- Completion
- 2024-05-28
- First posted
- 2022-01-04
- Last updated
- 2025-12-04
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05176535. Inclusion in this directory is not an endorsement.